Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 20 | 2024 | 951 | 4.090 |
Why?
|
Nerve Net | 12 | 2024 | 123 | 2.810 |
Why?
|
Magnetic Resonance Imaging | 17 | 2024 | 1328 | 1.750 |
Why?
|
Models, Theoretical | 5 | 2019 | 137 | 1.530 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2018 | 226 | 1.250 |
Why?
|
Data Interpretation, Statistical | 3 | 2019 | 109 | 0.990 |
Why?
|
Brain Mapping | 5 | 2022 | 178 | 0.980 |
Why?
|
Models, Neurological | 3 | 2019 | 117 | 0.780 |
Why?
|
Multivariate Analysis | 4 | 2018 | 684 | 0.690 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 3 | 2014 | 28 | 0.660 |
Why?
|
Databases, Factual | 4 | 2019 | 355 | 0.640 |
Why?
|
Software | 1 | 2018 | 123 | 0.600 |
Why?
|
Computer Simulation | 6 | 2024 | 220 | 0.600 |
Why?
|
Algorithms | 4 | 2018 | 495 | 0.560 |
Why?
|
Pesticides | 2 | 2017 | 199 | 0.550 |
Why?
|
Humans | 37 | 2024 | 32114 | 0.550 |
Why?
|
Models, Statistical | 4 | 2024 | 175 | 0.540 |
Why?
|
Occupational Exposure | 2 | 2017 | 232 | 0.540 |
Why?
|
Models, Biological | 3 | 2015 | 392 | 0.510 |
Why?
|
Feedback | 1 | 2015 | 43 | 0.510 |
Why?
|
Nicotine | 1 | 2017 | 174 | 0.490 |
Why?
|
Models, Cardiovascular | 1 | 2014 | 32 | 0.470 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 244 | 0.460 |
Why?
|
Caudate Nucleus | 1 | 2014 | 25 | 0.460 |
Why?
|
Schizophrenia | 1 | 2014 | 31 | 0.460 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2018 | 47 | 0.440 |
Why?
|
Hypertension | 3 | 2014 | 960 | 0.390 |
Why?
|
Computer Graphics | 1 | 2011 | 10 | 0.390 |
Why?
|
Longitudinal Studies | 3 | 2024 | 770 | 0.380 |
Why?
|
Myelin Sheath | 1 | 2010 | 12 | 0.370 |
Why?
|
Rest | 4 | 2022 | 53 | 0.350 |
Why?
|
Male | 21 | 2024 | 19217 | 0.330 |
Why?
|
Adult | 14 | 2019 | 9380 | 0.320 |
Why?
|
Female | 19 | 2024 | 20015 | 0.310 |
Why?
|
Neural Pathways | 3 | 2017 | 94 | 0.290 |
Why?
|
Regression Analysis | 3 | 2017 | 293 | 0.290 |
Why?
|
Aged | 14 | 2024 | 10314 | 0.290 |
Why?
|
Military Personnel | 2 | 2018 | 92 | 0.280 |
Why?
|
Weight Loss | 2 | 2022 | 480 | 0.270 |
Why?
|
Memory, Short-Term | 3 | 2016 | 60 | 0.270 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2017 | 24 | 0.270 |
Why?
|
Patient Admission | 2 | 2017 | 60 | 0.260 |
Why?
|
Young Adult | 7 | 2019 | 2665 | 0.260 |
Why?
|
Obesity | 3 | 2020 | 1176 | 0.260 |
Why?
|
Alcohol Drinking | 2 | 2019 | 255 | 0.250 |
Why?
|
Aged, 80 and over | 8 | 2024 | 3990 | 0.230 |
Why?
|
Comprehension | 2 | 2015 | 19 | 0.220 |
Why?
|
Leukoencephalopathies | 1 | 2023 | 12 | 0.220 |
Why?
|
Cognition | 3 | 2016 | 556 | 0.220 |
Why?
|
Independent Living | 1 | 2023 | 100 | 0.210 |
Why?
|
Aging | 3 | 2024 | 946 | 0.190 |
Why?
|
Neurons | 2 | 2015 | 410 | 0.190 |
Why?
|
Appetite | 1 | 2020 | 22 | 0.180 |
Why?
|
Allostasis | 2 | 2017 | 12 | 0.180 |
Why?
|
Acoustic Stimulation | 2 | 2018 | 126 | 0.180 |
Why?
|
Photography | 1 | 2019 | 44 | 0.170 |
Why?
|
Photic Stimulation | 1 | 2019 | 158 | 0.160 |
Why?
|
Blood Glucose | 2 | 2019 | 494 | 0.160 |
Why?
|
Normal Distribution | 2 | 2015 | 12 | 0.150 |
Why?
|
Electroencephalography | 1 | 2017 | 73 | 0.150 |
Why?
|
Time Factors | 4 | 2017 | 2151 | 0.150 |
Why?
|
Middle Aged | 9 | 2019 | 11839 | 0.150 |
Why?
|
Acetylcholinesterase | 1 | 2017 | 18 | 0.150 |
Why?
|
Butyrylcholinesterase | 1 | 2017 | 14 | 0.150 |
Why?
|
Probability | 1 | 2017 | 159 | 0.140 |
Why?
|
Temporal Lobe | 1 | 2017 | 30 | 0.140 |
Why?
|
Cotinine | 1 | 2017 | 49 | 0.140 |
Why?
|
Oxygen | 1 | 2017 | 142 | 0.140 |
Why?
|
Hospital Mortality | 1 | 2017 | 198 | 0.130 |
Why?
|
Infant, Newborn | 3 | 2017 | 672 | 0.130 |
Why?
|
Overweight | 1 | 2018 | 280 | 0.130 |
Why?
|
Insulin Resistance | 1 | 2019 | 462 | 0.130 |
Why?
|
Threshold Limit Values | 1 | 2015 | 2 | 0.130 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 412 | 0.130 |
Why?
|
Circadian Rhythm | 1 | 2015 | 43 | 0.130 |
Why?
|
Systole | 1 | 2015 | 99 | 0.130 |
Why?
|
Diastole | 1 | 2015 | 96 | 0.130 |
Why?
|
Drosophila melanogaster | 1 | 2015 | 42 | 0.120 |
Why?
|
Psychotropic Drugs | 1 | 2014 | 12 | 0.120 |
Why?
|
Sensation | 1 | 2015 | 55 | 0.120 |
Why?
|
Retrospective Studies | 3 | 2017 | 3510 | 0.120 |
Why?
|
Visual Perception | 1 | 2015 | 116 | 0.110 |
Why?
|
Critical Illness | 1 | 2014 | 87 | 0.110 |
Why?
|
Body Mass Index | 3 | 2024 | 923 | 0.110 |
Why?
|
Hippocampus | 1 | 2014 | 171 | 0.110 |
Why?
|
Odds Ratio | 4 | 2017 | 472 | 0.100 |
Why?
|
Body Weight | 1 | 2013 | 310 | 0.090 |
Why?
|
Politics | 1 | 2011 | 22 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 1128 | 0.090 |
Why?
|
Blood Pressure | 1 | 2015 | 845 | 0.090 |
Why?
|
Hispanic Americans | 1 | 2017 | 940 | 0.090 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2010 | 1 | 0.090 |
Why?
|
Anisotropy | 1 | 2010 | 11 | 0.090 |
Why?
|
Child | 4 | 2024 | 2442 | 0.090 |
Why?
|
Animals | 4 | 2015 | 7542 | 0.090 |
Why?
|
Rhinitis | 1 | 2010 | 11 | 0.090 |
Why?
|
African Americans | 2 | 2016 | 1425 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2013 | 291 | 0.080 |
Why?
|
Agricultural Workers' Diseases | 1 | 2010 | 85 | 0.080 |
Why?
|
Family Relations | 1 | 2008 | 23 | 0.080 |
Why?
|
Cohort Studies | 4 | 2015 | 1817 | 0.080 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 62 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2011 | 169 | 0.080 |
Why?
|
Health Services Accessibility | 1 | 2011 | 242 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 510 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 1428 | 0.080 |
Why?
|
Diet | 1 | 2010 | 391 | 0.070 |
Why?
|
Health Education | 1 | 2008 | 163 | 0.070 |
Why?
|
Social Support | 1 | 2008 | 182 | 0.070 |
Why?
|
Risk Factors | 4 | 2019 | 3880 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 94 | 0.070 |
Why?
|
Mississippi | 2 | 2019 | 27 | 0.070 |
Why?
|
Linear Models | 1 | 2007 | 449 | 0.070 |
Why?
|
Mass Screening | 1 | 2008 | 263 | 0.070 |
Why?
|
C-Reactive Protein | 2 | 2017 | 238 | 0.070 |
Why?
|
Child Nutrition Disorders | 1 | 2005 | 4 | 0.070 |
Why?
|
Prealbumin | 1 | 2005 | 9 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 548 | 0.060 |
Why?
|
Serum Albumin | 1 | 2005 | 54 | 0.060 |
Why?
|
Heart Rate | 2 | 2017 | 335 | 0.060 |
Why?
|
Child, Preschool | 3 | 2017 | 1270 | 0.060 |
Why?
|
Cerebral Palsy | 1 | 2005 | 62 | 0.060 |
Why?
|
Autistic Disorder | 1 | 2024 | 8 | 0.060 |
Why?
|
Attention | 1 | 2024 | 83 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 471 | 0.060 |
Why?
|
African Continental Ancestry Group | 2 | 2019 | 363 | 0.060 |
Why?
|
Muscle Strength | 1 | 2024 | 161 | 0.060 |
Why?
|
United States | 4 | 2017 | 3976 | 0.050 |
Why?
|
Infant | 2 | 2017 | 1062 | 0.050 |
Why?
|
Postural Balance | 1 | 2024 | 182 | 0.050 |
Why?
|
Anthropometry | 2 | 2016 | 83 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2019 | 765 | 0.050 |
Why?
|
North Carolina | 2 | 2017 | 1538 | 0.040 |
Why?
|
Adolescent | 3 | 2017 | 3568 | 0.040 |
Why?
|
Cues | 1 | 2019 | 68 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2017 | 33 | 0.040 |
Why?
|
Vasopressins | 1 | 2017 | 17 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2017 | 30 | 0.040 |
Why?
|
Epinephrine | 1 | 2017 | 40 | 0.040 |
Why?
|
Norepinephrine | 1 | 2017 | 77 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 73 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2018 | 106 | 0.040 |
Why?
|
Veterans | 1 | 2017 | 68 | 0.040 |
Why?
|
Resistance Training | 1 | 2018 | 82 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 112 | 0.040 |
Why?
|
Quality of Life | 1 | 2023 | 946 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2017 | 43 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2017 | 247 | 0.030 |
Why?
|
Waist Circumference | 1 | 2016 | 90 | 0.030 |
Why?
|
Demography | 1 | 2016 | 110 | 0.030 |
Why?
|
Leptin | 1 | 2016 | 71 | 0.030 |
Why?
|
Baroreflex | 1 | 2017 | 84 | 0.030 |
Why?
|
Angiotensin II | 1 | 2017 | 244 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2016 | 177 | 0.030 |
Why?
|
Adiponectin | 1 | 2016 | 106 | 0.030 |
Why?
|
Prevalence | 1 | 2019 | 989 | 0.030 |
Why?
|
Angiotensin I | 1 | 2017 | 241 | 0.030 |
Why?
|
Triglycerides | 1 | 2016 | 230 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2018 | 270 | 0.030 |
Why?
|
Research Design | 1 | 2017 | 315 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2017 | 399 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 51 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 1542 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2014 | 72 | 0.030 |
Why?
|
Life Style | 1 | 2016 | 408 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2015 | 371 | 0.030 |
Why?
|
Action Potentials | 1 | 2014 | 178 | 0.030 |
Why?
|
Urban Health | 1 | 2013 | 15 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2014 | 464 | 0.030 |
Why?
|
Incidence | 1 | 2016 | 1199 | 0.030 |
Why?
|
Risk Assessment | 1 | 2019 | 1429 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 633 | 0.030 |
Why?
|
Exercise | 1 | 2018 | 673 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 2265 | 0.020 |
Why?
|
Sex Factors | 1 | 2013 | 667 | 0.020 |
Why?
|
Health Policy | 1 | 2011 | 89 | 0.020 |
Why?
|
Rats | 1 | 2014 | 1596 | 0.020 |
Why?
|
Captan | 1 | 2010 | 1 | 0.020 |
Why?
|
Petroleum | 1 | 2010 | 1 | 0.020 |
Why?
|
Diazinon | 1 | 2010 | 3 | 0.020 |
Why?
|
Iowa | 1 | 2010 | 9 | 0.020 |
Why?
|
Acetamides | 1 | 2010 | 7 | 0.020 |
Why?
|
Information Seeking Behavior | 1 | 2008 | 11 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2008 | 149 | 0.020 |
Why?
|
Health Surveys | 1 | 2008 | 198 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2008 | 240 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2008 | 172 | 0.020 |
Why?
|
Decision Making | 1 | 2008 | 195 | 0.020 |
Why?
|
Logistic Models | 1 | 2008 | 783 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2005 | 55 | 0.020 |
Why?
|
European Continental Ancestry Group | 1 | 2008 | 1166 | 0.010 |
Why?
|